Loomis, Sayles & Company’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $53.4K | Sell |
200
-229
| -53% | -$63.4K | ﹤0.01% | 616 |
|
|
2025
Q4 | $118K | Buy |
429
+328
| +325% | +$92K | ﹤0.01% | 568 |
|
|
2025
Q3 | $29.1K | Buy |
101
+2
| +2% | +$592 | ﹤0.01% | 672 |
|
|
2025
Q2 | $32.7K | Sell |
99
-21
| -18% | -$6.77K | ﹤0.01% | 657 |
|
|
2025
Q1 | $39K | Sell |
120
-105
| -47% | -$31.6K | ﹤0.01% | 654 |
|
|
2024
Q4 | $62K | Sell |
225
-21
| -9% | -$6.69K | ﹤0.01% | 625 |
|
|
2024
Q3 | $85K | Buy |
246
+43
| +21% | +$14.8K | ﹤0.01% | 566 |
|
|
2024
Q2 | $67K | Buy |
203
+4
| +2% | +$1.38K | ﹤0.01% | 594 |
|
|
2024
Q1 | $72K | Sell |
199
-16
| -7% | -$5.27K | ﹤0.01% | 574 |
|
|
2023
Q4 | $64K | Sell |
215
-4
| -2% | -$1.17K | ﹤0.01% | 581 |
|
|
2023
Q3 | $63K | Buy |
219
+31
| +16% | +$8.84K | ﹤0.01% | 578 |
|
|
2023
Q2 | $53K | Buy |
188
+7
| +4% | +$1.82K | ﹤0.01% | 602 |
|
|
2023
Q1 | $46K | Buy |
181
+75
| +71% | +$21.9K | ﹤0.01% | 629 |
|
|
2022
Q4 | $35K | Buy |
106
+44
| +71% | +$13.9K | ﹤0.01% | 658 |
|
|
2022
Q3 | $17K | Sell |
62
-43
| -41% | -$12.1K | ﹤0.01% | 621 |
|
|
2022
Q2 | $28K | Sell |
105
-14
| -12% | -$3.61K | ﹤0.01% | 574 |
|
|
2022
Q1 | $29K | Sell |
119
-27
| -18% | -$6.32K | ﹤0.01% | 609 |
|
|
2021
Q4 | $34K | Sell |
146
-51
| -26% | -$10.8K | ﹤0.01% | 630 |
|
|
2021
Q3 | $39K | Buy |
197
+3
| +2% | +$652 | ﹤0.01% | 613 |
|
|
2021
Q2 | $46K | Buy |
194
+15
| +8% | +$3.75K | ﹤0.01% | 590 |
|
|
2021
Q1 | $43K | Buy |
179
+20
| +13% | +$4.46K | ﹤0.01% | 572 |
|
|
2020
Q4 | $33K | Sell |
159
-4,362
| -96% | -$856K | ﹤0.01% | 580 |
|
|
2020
Q3 | $766K | Sell |
4,521
-605
| -12% | -$106K | ﹤0.01% | 477 |
|
|
2020
Q2 | $962K | Buy |
5,126
+4,975
| +3,295% | +$944K | ﹤0.01% | 459 |
|
|
2020
Q1 | $27K | Sell |
151
-525
| -78% | -$102K | ﹤0.01% | 568 |
|
|
2019
Q4 | $138K | Buy |
676
+61
| +10% | +$11.2K | ﹤0.01% | 550 |
|
|
2019
Q3 | $93K | Buy |
+615
| New | +$100K | ﹤0.01% | 556 |
|
|
2019
Q2 | – | Sell |
-21,950
| Closed | -$3.53M | – | 594 |
|
|
2019
Q1 | $3.53M | Buy |
21,950
+10,711
| +95% | +$1.96M | 0.01% | 465 |
|
|
2018
Q4 | $2.13M | Buy |
+11,239
| New | +$2.34M | 0.01% | 505 |
|
|
2018
Q3 | – | Sell |
-152
| Closed | -$26K | – | 897 |
|
|
2018
Q2 | $26K | Buy |
152
+18
| +13% | +$3.12K | ﹤0.01% | 727 |
|
|
2018
Q1 | $22K | Hold |
134
| – | – | ﹤0.01% | 765 |
|
|
2017
Q4 | $27K | Buy |
134
+88
| +191% | +$17.5K | ﹤0.01% | 729 |
|
|
2017
Q3 | $9K | Hold |
46
| – | – | ﹤0.01% | 795 |
|
|
2017
Q2 | $8K | Buy |
+46
| New | +$7.39K | ﹤0.01% | 810 |
|
|
2016
Q2 | – | Sell |
-3,900
| Closed | -$535K | – | 1023 |
|
|
2016
Q1 | $535K | Sell |
3,900
-1,894
| -33% | -$260K | ﹤0.01% | 611 |
|
|
2015
Q4 | $848K | Hold |
5,794
| – | – | ﹤0.01% | 594 |
|
|
2015
Q3 | $782K | Sell |
5,794
-1,318
| -19% | -$191K | ﹤0.01% | 572 |
|
|
2015
Q2 | $1.15M | Hold |
7,112
| – | – | ﹤0.01% | 560 |
|
|
2015
Q1 | $921K | Sell |
7,112
-17
| -0.2% | -$1.98K | ﹤0.01% | 600 |
|
|
2014
Q4 | $734K | Buy |
7,129
+1,082
| +18% | +$107K | ﹤0.01% | 585 |
|
|
2014
Q3 | $548K | Buy |
+6,047
| New | +$565K | ﹤0.01% | 600 |
|
|
2014
Q2 | – | Sell |
-4,546
| Closed | -$381K | – | 749 |
|
|
2014
Q1 | $381K | Sell |
4,546
-4,993
| -52% | -$411K | ﹤0.01% | 608 |
|
|
2013
Q4 | $834K | Hold |
9,539
| – | – | ﹤0.01% | 631 |
|
|
2013
Q3 | $733K | Sell |
9,539
-60
| -0.6% | -$4.68K | ﹤0.01% | 619 |
|
|
2013
Q2 | $696 | Buy |
+9,599
| New | +$647K | ﹤0.01% | 609 |
|
Other funds holding CI
VCM
VPM
Loomis, Sayles & Company's CI Position: Q1 2026 in Review
Loomis, Sayles & Company reduced its Cigna (CI) stake by 53% in Q1 2026, selling an estimated $63.4K and leaving 200 shares worth $53.4K. The position accounts for ﹤0.01% of the portfolio, ranked #616.
Loomis, Sayles & Company first reported a position in CI in Q2 2013 and has held it in 45 quarters since. The position peaked at $3.53M in Q1 2019. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.
- Loomis, Sayles & Company held 200 shares of Cigna worth $53.4K as of Q1 2026.
- Loomis, Sayles & Company sold 229 Cigna shares in Q1 2026, an estimated $63.4K.
- Cigna made up ﹤0.01% of Loomis, Sayles & Company's portfolio in Q1 2026, its #616 holding.
- Loomis, Sayles & Company first reported a position in Cigna in Q2 2013 and has held it in 45 quarters since.
- Loomis, Sayles & Company's Cigna position peaked at $3.53M in Q1 2019.
- 1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.
Based on Loomis, Sayles & Company's 13F filing for Q1 2026, filed 14 May 2026.